Kestra Medical Technologies, Ltd. (NASDAQ: KMTS) reported Q2 EPS of ($0.67), $0.09 worse than the analyst estimate of ($0.58). Revenue for the quarter came in at $28.64 million, versus $26.5 million reported last year.

For earnings history and earnings-related data on Kestra Medical Technologies, Ltd. (KMTS) click here.